Hypothyroidism and Non-alcoholic Fatty Liver Disease: Association and Effect of Levothyroxine Replacement Therapy | ||||
| The Egyptian Family Medicine Journal | ||||
| Article 6, Volume 5, Issue 1, May 2021, Page 52-67 PDF (375.29 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/efmj.2021.26839.1022 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mokhtar M. Shatla   1; Ahmed S. Faisal2
| ||||
| 17432 Al-Awaly | ||||
| 2Department of Infectious Diseases, Suez Canal Faculty of Medicine, Suez Canal University, Ismailia, Egypt, and Department of Infectious Diseases, Umm Alqura Medical Center, Umm Alqura University, Makkah, Saudi Arabia. | ||||
| Abstract | ||||
| Background: The association between hypothyroidism and non-alcoholic fatty liver disease (NAFLD) is increasingly studied with controversial results, and evidences regarding the effect of levothyroxine replacement therapy on NAFLD are lacking. Objectives: to examine the association between overt hypothyroidism and NAFLD, and to test the effect of levothyroxine (LT4) replacement therapy on NAFLD among subjects with overt hypothyroidism. Methods: 325 recently diagnosed overt hypothyroidism subjects were compared to 325 age, sex, and BMI matched subjects regarding metabolic characteristics, serum liver enzymes, and ultrasound diagnosed NAFLD. The same comparison was performed on subjects with NAFLD in the case group before and after 12 months of LT4 replacement therapy. Results: The mean age of participants was 45.22±5.04 years old, and 369 (56.8) were females. Subjects with overt hypothyroidism had a significantly higher prevalence of NAFLD [146 (44.9) versus 83 (25.5), p < 0.001], and higher means of metabolic variables, liver enzymes, and ultrasound liver measurements (p < 0.5). At 12 months of LT4 therapy, there was 35.6% reduction in the prevalence of NAFLD (p < 0.001), and significantly reduced values of metabolic variables, and serum liver enzymes (p < 0.05) among subjects with NAFLD in the case group. Conclusions: Overt hypothyroidism was significantly associated with NAFLD. Moreover, 12 months LT4 replacement therapy significantly reduced the prevalence of NAFLD. | ||||
| Keywords | ||||
| Levothyroxine replacement; non-alcoholic fatty liver disease; overt hypothyroidism | ||||
|
Statistics Article View: 216 PDF Download: 364 |
||||
